BioSenic releases details of optimized administration
INSIDE INFORMATION New data builds on earlier findings from a post-hoc Phase 2 analysis that helped reposition BioSenic’s oral arsenic ...
Read moreINSIDE INFORMATION New data builds on earlier findings from a post-hoc Phase 2 analysis that helped reposition BioSenic’s oral arsenic ...
Read morePRESS RELEASE – INSIDE INFORMATION BioSenic patent granted in Canada for broader protection of its ATO therapeutic platform Composition-of-matter ...
Read morePRESS RELEASE BioSenic presents new Phase 3 data on JTA-004 to treat severe osteoarthritis pain at the 2024 OARSI World ...
Read morePRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, ...
Read morePRESS RELEASE – INSIDE INFORMATION BioSenic reaches agreement on a binding term sheet with Phebra PTY Ltd. with respect to ...
Read moreBioSenic signs a new subscription agreement for a maximum of EUR 1.2M in convertible bonds Mont-Saint-Guibert, Belgium, January 8, 2024, ...
Read morePRESS RELEASE – INSIDE INFORMATION This is a corrected version of the original PR " BioSenic on its way to ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.